Johnson & Johnson
Recent News About Johnson & Johnson View More
-
Johnson & Johnson to pay $586,408 settlement to Louisiana for selling defective medicines
The crux of the settlement resolves allegations that Johnson & Johnson sold medicines that did not meet federal quality requirements. -
Johnson & Johnson, Bayer win second trial over Xarelto bleeding risks
&&&A federal jury in New Orleans has cleared Johnson & Johnson and Bayer AG in the second of at least 18,600 suits filed against the pharmaceutical giants stemming from the manufacturing of the blood-thinning drug Xarelto. -
.jpg)
Johnson & Johnson, Bayer prevail in first of 18,000 Xarelto trials
After emerging victorious in the first of more than 18,000 suits filed against them, Xarelto maker Johnson & Johnson and Bayer Pharmaceuticals are vowing to remain as vigilant as ever in defending their reputations. -
Xarelto makers win first case, prepare to defend others
The companies defending a lawsuit filed against them for safety concerns over blood-thinning drug Xarelto say their first win in a string of bellwether court cases bolsters their claims the drug is safe and contains proper patient warnings. -
Johnson & Johnson ovarian cancer claims called into question
NEW ORLEANS — A Louisiana woman has filed suit against Johnson & Johnson, claiming the company’s baby powder caused her ovarian cancer. -
Consumer claims Johnson & Johnson, Bayer alleged misled patients about the safety of Xarelto
NEW ORLEANS — A consumer has filed suit against several defendants for alleged breach of express and implied warranties, fraudulent misrepresentation and concealment, fraud and deceit. -
Class actions brewing in state over Johnson & Johnson baby powder and cancer
NEW ORLEANS – A local attorney and legal watchdog organization both expect to see class-action lawsuits filed in the state over allegations that Johnson & Johnson's Baby Powder and Shower to Shower products cause ovarian cancer.